{"id":34377,"topic":"peptides","source":"Foley & Lardner LLP","title":"FDA to Consider Lifting Restrictions on Numerous Compounded Peptides - Foley & Lardner LLP","url":"https://www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","url_hash":"47f010fc58506ea2f2f5192e4e5dcbda77497122","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQTmhJajlMcmtESDNmZWg1OVBmMUF0YmlJd1BCRmg3dWZYUGJnNFdXeUhKeG9xRjFaTXZwSkd4eGhIMF9XYnNaTWtPY1otV01WTG9YTG1CVGpiRVI1ZlhvOERGSVEzYUI5M1RpUnc2WHFfX2ZYNVctM3lRaGRwd3BSUllUenBwZ0JxN0lWd0hYZW5ZaTJYcjc0dVRVaE40bDdJOXNkTm5Cb2ZfZ05Qb1dFV244M3czSTZTQnRjSjB3?oc=5\" target=\"_blank\">FDA to Consider Lifting Restrictions on Numerous Compounded Peptides</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Foley & Lardner LLP</font>","content":null,"image_url":null,"lang":"en","published_at":"2026-05-05T07:00:00+00:00","fetched_at":"2026-07-12T01:15:09+00:00","status":"read","starred":0,"extract_state":"failed","summary_auto":null,"cluster_id":null,"extract_retries":2,"extract_error":"trafilatura_none","contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":461,"usable_text_length":461,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":461}},"news_item":{"id":34377,"canonical_url":"https://www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","source_url":"https://www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","title":"FDA to Consider Lifting Restrictions on Numerous Compounded Peptides - Foley & Lardner LLP","source_name":"Foley & Lardner LLP","author":null,"published_at":"2026-05-05T07:00:00+00:00","locale":"en","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQTmhJajlMcmtESDNmZWg1OVBmMUF0YmlJd1BCRmg3dWZYUGJnNFdXeUhKeG9xRjFaTXZwSkd4eGhIMF9XYnNaTWtPY1otV01WTG9YTG1CVGpiRVI1ZlhvOERGSVEzYUI5M1RpUnc2WHFfX2ZYNVctM3lRaGRwd3BSUllUenBwZ0JxN0lWd0hYZW5ZaTJYcjc0dVRVaE40bDdJOXNkTm5Cb2ZfZ05Qb1dFV244M3czSTZTQnRjSjB3?oc=5\" target=\"_blank\">FDA to Consider Lifting Restrictions on Numerous Compounded Peptides</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Foley & Lardner LLP</font>","full_text":null,"excerpt":"<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQTmhJajlMcmtESDNmZWg1OVBmMUF0YmlJd1BCRmg3dWZYUGJnNFdXeUhKeG9xRjFaTXZwSkd4eGhIMF9XYnNaTWtPY1otV01WTG9YTG1CVGpiRVI1ZlhvOERGSVEzYUI5M1RpUnc2WHFfX2ZYNVctM3lRaGRwd3BSUllUenBwZ0JxN0lWd0hYZW5ZaTJYcjc0dVRVaE40bDdJOXNkTm5Cb2ZfZ05Qb1dFV244M3czSTZTQnRjSjB3?oc=5\" target=\"_blank\">FDA to Consider Lifting Restrictions on Numerous Compounded Peptides</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Foley & Lardner LLP</font>","extraction":{"state":"failed","confidence":0.2,"error":"trafilatura_none","explanation":"Low confidence: extractor returned no usable article text.","diagnostics_url":"/api/diagnose?url=https%3A//www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":461,"usable_text_length":461,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":461}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"FDA to Consider Lifting Restrictions on Numerous Compounded Peptides - Foley & Lardner LLP","url":"https://www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","summary":"<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQTmhJajlMcmtESDNmZWg1OVBmMUF0YmlJd1BCRmg3dWZYUGJnNFdXeUhKeG9xRjFaTXZwSkd4eGhIMF9XYnNaTWtPY1otV01WTG9YTG1CVGpiRVI1ZlhvOERGSVEzYUI5M1RpUnc2WHFfX2ZYNVctM3lRaGRwd3BSUllUenBwZ0JxN0lWd0hYZW5ZaTJYcjc0dVRVaE40bDdJOXNkTm5Cb2ZfZ05Qb1dFV244M3czSTZTQnRjSjB3?oc=5\" target=\"_blank\">FDA to Consider Lifting Restrictions on Numerous Compounded Peptides</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Foley & Lardner LLP</font>","source":"Foley & Lardner LLP","date":"2026-05-05T07:00:00+00:00","content":"","confidence":0.2,"diagnostics_url":"/api/diagnose?url=https%3A//www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","quality_bucket":"low","failure_kind":"extractor_empty","retryable":false,"quality_reason":"Low confidence: extractor returned no usable article text.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":461,"usable_text_length":461,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":461}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/34377","export_markdown":"/api/items/34377/export?format=markdown","export_json":"/api/items/34377/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/"},"formats":{"full":{"id":34377,"title":"FDA to Consider Lifting Restrictions on Numerous Compounded Peptides - Foley & Lardner LLP","url":"https://www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","source":"Foley & Lardner LLP","author":null,"published_at":"2026-05-05T07:00:00+00:00","locale":"en","topic":"peptides","tags":[],"excerpt":"<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQTmhJajlMcmtESDNmZWg1OVBmMUF0YmlJd1BCRmg3dWZYUGJnNFdXeUhKeG9xRjFaTXZwSkd4eGhIMF9XYnNaTWtPY1otV01WTG9YTG1CVGpiRVI1ZlhvOERGSVEzYUI5M1RpUnc2WHFfX2ZYNVctM3lRaGRwd3BSUllUenBwZ0JxN0lWd0hYZW5ZaTJYcjc0dVRVaE40bDdJOXNkTm5Cb2ZfZ05Qb1dFV244M3czSTZTQnRjSjB3?oc=5\" target=\"_blank\">FDA to Consider Lifting Restrictions on Numerous Compounded Peptides</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Foley & Lardner LLP</font>","full_text":null,"reading_time_min":1,"extraction":{"state":"failed","confidence":0.2,"error":"trafilatura_none","explanation":"Low confidence: extractor returned no usable article text.","diagnostics_url":"/api/diagnose?url=https%3A//www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":461,"usable_text_length":461,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":461}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":461,"usable_text_length":461,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":461}},"actions":{"read":"/item/34377","export_markdown":"/api/items/34377/export?format=markdown","export_json":"/api/items/34377/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/"}},"digest":{"id":34377,"title":"FDA to Consider Lifting Restrictions on Numerous Compounded Peptides - Foley & Lardner LLP","url":"https://www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","source":"Foley & Lardner LLP","topic":"peptides","published_at":"2026-05-05T07:00:00+00:00","excerpt":"<a…","quality_bucket":"low","quality_reason":"Low confidence: extractor returned no usable article text.","reading_time_min":1,"cluster_id":null},"card":{"display_title":"FDA to Consider Lifting Restrictions on Numerous Compounded Peptides - Foley & Lardner LLP","subtitle":"Foley & Lardner LLP · 2026-05-05","summary":"<a…","badges":["quality:low","issue:extractor_empty"],"links":{"read":"/item/34377","original":"https://www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","diagnose":"/api/diagnose?url=https%3A//www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/"},"quality_warning":"Low confidence: extractor returned no usable article text."},"export":{"title":"FDA to Consider Lifting Restrictions on Numerous Compounded Peptides - Foley & Lardner LLP","url":"https://www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","summary":"<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQTmhJajlMcmtESDNmZWg1OVBmMUF0YmlJd1BCRmg3dWZYUGJnNFdXeUhKeG9xRjFaTXZwSkd4eGhIMF9XYnNaTWtPY1otV01WTG9YTG1CVGpiRVI1ZlhvOERGSVEzYUI5M1RpUnc2WHFfX2ZYNVctM3lRaGRwd3BSUllUenBwZ0JxN0lWd0hYZW5ZaTJYcjc0dVRVaE40bDdJOXNkTm5Cb2ZfZ05Qb1dFV244M3czSTZTQnRjSjB3?oc=5\" target=\"_blank\">FDA to Consider Lifting Restrictions on Numerous Compounded Peptides</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Foley & Lardner LLP</font>","source":"Foley & Lardner LLP","date":"2026-05-05T07:00:00+00:00","content":"","confidence":0.2,"diagnostics_url":"/api/diagnose?url=https%3A//www.foley.com/insights/publications/2026/05/fda-to-consider-lifting-restrictions-on-numerous-compounded-peptides/","quality_bucket":"low","failure_kind":"extractor_empty","retryable":false,"quality_reason":"Low confidence: extractor returned no usable article text.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":461,"usable_text_length":461,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":461}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}